Evidence map›Paper›PMID 37655816›Full record

SynthesisThe British journal of psychiatry : the journal of mental science2023

Telepsychiatry versus face-to-face treatment: systematic review and meta-analysis of randomised controlled trials.

Katsuhiko Hagi, Shunya Kurokawa, Akihiro Takamiya, Mayu Fujikawa, Shotaro Kinoshita, Mari Iizuka, Shota Furukawa, Yoko Eguchi, Taishiro Kishimoto

Open access · hybridAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in The British journal of psychiatry : the journal of mental science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 6 pooled it
14.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 6 syntheses or guidelines pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Engagement and Outcomes Associated With Message-Based Psychotherapy Among Older and Younger Adults.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2026
    Article
  13. Review
  14. Article
  15. Article
  16. Observational
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Katsuhiko HagiMedical Affairs, Sumitomo Pharma Co., Tokyo, Japan.ORCID https://orcid.org/0000-0003-1389-1474
Shunya KurokawaDepartment of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Akihiro TakamiyaDepartment of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Mayu FujikawaDepartment of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan; and Department of Epileptology, Tohoku University School of Medicine, Miyagi, Japan.
Shotaro KinoshitaHills Joint Research Laboratory for Future Preventive Medicine and Wellness, Keio University School of Medicine, Tokyo, Japan; and Graduate School of Interdisciplinary Information Studies, University of Tokyo, Tokyo, Japan.ORCID https://orcid.org/0000-0002-8168-383X
Mari IizukaDepartment of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Shota FurukawaDepartment of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan; Hills Joint Research Laboratory for Future Preventive Medicine and Wellness, Keio University School of Medicine, Tokyo, Japan; and Tsutsuji Mental Hospital, Gunma, Japan.
Yoko EguchiDepartment of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Taishiro KishimotoDepartment of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan; Hills Joint Research Laboratory for Future Preventive Medicine and Wellness, Keio University School of Medicine, Tokyo, Japan; Department of Psychiatry, Zucker Hillside Hospital, Northwell Health, Glen Oaks, New York, USA; Department of Psychiatry, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, USA; Department of Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, USA; and Feinstein Institute for Medical Research, Center for Psychiatric Neuroscience, Manhasset, New York, USA.ORCID https://orcid.org/0000-0003-0557-8648
Keio University · JPNorthwell Health · USSumitomo Dainippon Pharma (Japan) · JPToho University · JPTokyo University of Information Sciences · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe COVID-19 pandemic has transformed healthcare significantly and telepsychiatry is now the primary means of treatment in some countries.

aimsTo compare the efficacy of telepsychiatry and face-to-face treatment.

methodA comprehensive meta-analysis comparing telepsychiatry with face-to-face treatment for psychiatric disorders. The primary outcome was the mean change in the standard symptom scale scores used for each psychiatric disorder. Secondary outcomes included all meta-analysable outcomes, such as all-cause discontinuation and safety/tolerability.

resultsWe identified 32 studies (

conclusionsTelepsychiatry achieved a symptom improvement effect for various psychiatric disorders similar to that of face-to-face treatment. However, some superiorities/inferiorities were seen across a few specific psychiatric disorders, suggesting that its efficacy may vary according to disease type.

Indexed as

Cognitive DysfunctionCOVID-19PsychiatryTelemedicineHumansPandemicsRandomized Controlled Trials as Topicmeta-analysisteleconferencingtelemedicineTelepsychiatryvideoconferencing in psychiatry

Identifiers

PMID37655816
PMCPMC10895502
OpenAlexW4386347508

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.